MedPath

In-line Filters on ICU

Completed
Conditions
Micropore Filters
Registration Number
NCT02281604
Lead Sponsor
Johann Wolfgang Goethe University Hospital
Brief Summary

The purpose of this study is to determine whether the use of 0.2/1.2 microliter in-line filter reduces the incidence of severe vasoplegia comparing to the 5 microliter filter.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
3281
Inclusion Criteria
  • all patients
Exclusion Criteria
  • Younger than 18 years

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Incidence of severe vasoplegiaparticipants will be followed for the duration of intensive care unit stay, an expected average of 1 week
Secondary Outcome Measures
NameTimeMethod
Duration of ICU and hospital stayparticipants will be followed for the duration of intensive care unit/ hospital stay, an expected average of 1 or 4 week (s), respectively
Morbidityparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks

Incidence of preoperative myocardial infarction, stroke, pneumonia, sepsis and acute kidney failure according to routine documentation

Inflammationparticipants will be followed for the duration of intensive care unit stay, an expected average of 1 week

Interleukin-6

In-hospital mortalityparticipants will be followed for the duration of hospital stay, an expected average of 4 weeks
Organ dysfunctionparticipants will be followed for the duration of intensive care unit stay, an expected average of 1 week

Severity of organdysfunction (SOFA-Score), incidence and severity of respiratory failure (Horovitz- Index), incidence and severity of acute kidney failure (RIFLE criteria), incidence and severity of delirium

© Copyright 2025. All Rights Reserved by MedPath